Homocystinuria due to methylene tetrahydrofolate reductase deficiency Advocacy Hub | UniteRare

At a Glance

Live from database

💊

2FDA treatments

💰

1Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Homocystinuria due to methylene tetrahydrofolate reductase deficiency.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Betaine Anhydrous

Eton Pharmaceuticals, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

2 FDA-approved

Cystadane

(BETAINE)Orphan drugstandard

Recordati Rare Diseases

Methylating Agent [EPC]

FDA label ↗

Betaine Anhydrous

(BETAINE ANHYDROUS)Orphan drugstandard

Eton Pharmaceuticals, Inc.

Methylating Agent [EPC]

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Homocystinuria due to methylene tetrahydrofolate reductase deficiency.
Search all trials →

Search clinical trials for Homocystinuria due to methylene tetrahydrofolate reductase deficiency →

Recent News & Research

No recent news articles indexed yet for Homocystinuria due to methylene tetrahydrofolate reductase deficiency.
Search PubMed for Homocystinuria due to methylene tetrahydrofolate reductase deficiency →

Browse all Homocystinuria due to methylene tetrahydrofolate reductase deficiency news →

Specialist Network

No specialists currently listed for Homocystinuria due to methylene tetrahydrofolate reductase deficiency.

View all Homocystinuria due to methylene tetrahydrofolate reductase deficiency specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰